Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-R Taskinen

Showing results (171-180 of 269) with videos related to

Pageof 27
Sort By:
Diabetes/Metabolism Research and Reviews|February 23, 2005
No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetesE H Johanson, P-A Jansson, B Gustafson, et al.
Diabetes, Obesity & Metabolism|December 1, 2010
Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled studyM-R Taskinen, J Rosenstock, I Tamminen, et al.
Diabetes Care|April 24, 2001
Cardiovascular morbidity and mortality associated with the metabolic syndromeB Isomaa, P Almgren, T Tuomi, et al.
Journal of Lipid Research|March 3, 2004
Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresisD R Witte, M R Taskinen, H Perttunen-Nio, et al.
Diabetologia|August 10, 2011
Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia StudyP Almgren, M Lehtovirta, B Isomaa, et al.
Diabetes|July 1, 1996
Multiple lipoprotein abnormalities in type I diabetic patients with renal diseaseP H Groop, T Elliott, A Ekstrand, et al.
Atherosclerosis|March 21, 1997
Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal womenM Tilly-Kiesi, J Kahri, T Pyörälä, et al.
Journal of Lipid Research|July 31, 1998
Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activitiesN Mero, A Van Tol, L M Scheek, et al.
Journal of Internal Medicine|May 8, 2021
Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetesF Jansson Sigfrids, E H Dahlström, C Forsblom, et al.
Atherosclerosis|April 9, 2025
Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humansC J Packard, M R Taskinen, E Björnson, et al.
Pageof 27

Showing results (171-180 of 269) with videos related to

Sort By:
Pageof 27
Diabetes/Metabolism Research and Reviews|February 23, 2005
No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetesE H Johanson, P-A Jansson, B Gustafson, et al.
Diabetes, Obesity & Metabolism|December 1, 2010
Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled studyM-R Taskinen, J Rosenstock, I Tamminen, et al.
Diabetes Care|April 24, 2001
Cardiovascular morbidity and mortality associated with the metabolic syndromeB Isomaa, P Almgren, T Tuomi, et al.
Journal of Lipid Research|March 3, 2004
Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresisD R Witte, M R Taskinen, H Perttunen-Nio, et al.
Diabetologia|August 10, 2011
Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia StudyP Almgren, M Lehtovirta, B Isomaa, et al.
Diabetes|July 1, 1996
Multiple lipoprotein abnormalities in type I diabetic patients with renal diseaseP H Groop, T Elliott, A Ekstrand, et al.
Atherosclerosis|March 21, 1997
Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal womenM Tilly-Kiesi, J Kahri, T Pyörälä, et al.
Journal of Lipid Research|July 31, 1998
Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activitiesN Mero, A Van Tol, L M Scheek, et al.
Journal of Internal Medicine|May 8, 2021
Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetesF Jansson Sigfrids, E H Dahlström, C Forsblom, et al.
Atherosclerosis|April 9, 2025
Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humansC J Packard, M R Taskinen, E Björnson, et al.
Pageof 27